“…Μ leprae antigens were kindly provided by Dr Μ Abe (Nat Inst Leprosy Research, Fokyo Japan) and by Dr R C Good (Centre for Infectious Diseases, CDC, Atlanta GA) Both preparations consisted of bacilii isolated from human tepromas aecording to Dharmendia's proceduie [14J with siight modifications The end concentrations of the fnsl preparation m the cultures are given in μg/ml, whereas those of the second preparation are txpressed as final diiution in the cultures The 9 3 mAb was onginaily prepared by Hansen et al [4] For the present expenments, the 9 3 mAb was bought from New Tngland Nuclear (Boston, MA), it was punfied by protein Α aifinity chromatography and found to bc homogeneous by SDS gel electrophoresis Other monoclonai antibodies used were directed against ciass I majoi histocom patibihty antigen, 9455 SA/BRL, W6/32, B9 12 1 (couitesy of Dr Β Mahssen), ßi-microglobulm, Bl 1 G 6 (courtesy of Di Β Mahssen), T3 antigen W132(RIV Bilthoven), T4, RIV6 Γ8, IK18, transferrm reeeptor, 6 Κ 22 1, I F Α 1, 8 3 14 1, DR, B8 11 2 (courtesy Dr Β Mahssen), DQ, SP V L3 8 (courtesy Dr Η Spits), 3Al-hke determmant, 64 5 1 and Ob,, PdV 10 2…”